Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Quercetin-Induced miR-369-3p Suppresses Chronic Inflammatory Response Targeting C/EBP-β.

Galleggiante V, De Santis S, Liso M, Verna G, Sommella E, Mastronardi M, Campiglia P, Chieppa M, Serino G.

Mol Nutr Food Res. 2019 Oct;63(19):e1801390. doi: 10.1002/mnfr.201801390. Epub 2019 Jul 31.

PMID:
31338984
2.

Corrigendum: Aquaporin-9 Contributes to the Maturation Process and Inflammatory Cytokine Secretion of Murine Dendritic Cells.

De Santis S, Serino G, Fiorentino MR, Galleggiante V, Gena P, Verna G, Liso M, Massaro M, Lan J, Troisi J, Cataldo I, Bertamino A, Pinto A, Campiglia P, Santino A, Giannelli G, Fasano A, Calamita G, Chieppa M.

Front Immunol. 2019 Feb 25;10:216. doi: 10.3389/fimmu.2019.00216. eCollection 2019.

3.

A Bronze-Tomato Enriched Diet Affects the Intestinal Microbiome under Homeostatic and Inflammatory Conditions.

Liso M, De Santis S, Scarano A, Verna G, Dicarlo M, Galleggiante V, Campiglia P, Mastronardi M, Lippolis A, Vacca M, Sobolewski A, Serino G, Butelli E, De Angelis M, Martin C, Santino A, Chieppa M.

Nutrients. 2018 Dec 2;10(12). pii: E1862. doi: 10.3390/nu10121862.

4.

Aquaporin 9 Contributes to the Maturation Process and Inflammatory Cytokine Secretion of Murine Dendritic Cells.

De Santis S, Serino G, Fiorentino MR, Galleggiante V, Gena P, Verna G, Liso M, Massaro M, Lan J, Troisi J, Cataldo I, Bertamino A, Pinto A, Campiglia P, Santino A, Giannelli G, Fasano A, Calamita G, Chieppa M.

Front Immunol. 2018 Oct 16;9:2355. doi: 10.3389/fimmu.2018.02355. eCollection 2018. Erratum in: Front Immunol. 2019 Feb 25;10:216.

5.

Secretory Leukoprotease Inhibitor (Slpi) Expression Is Required for Educating Murine Dendritic Cells Inflammatory Response Following Quercetin Exposure.

De Santis S, Galleggiante V, Scandiffio L, Liso M, Sommella E, Sobolewski A, Spilotro V, Pinto A, Campiglia P, Serino G, Santino A, Notarnicola M, Chieppa M.

Nutrients. 2017 Jul 6;9(7). pii: E706. doi: 10.3390/nu9070706.

6.

Iron Chelators Dictate Immune Cells Inflammatory Ability: Potential Adjuvant Therapy for IBD.

Chieppa M, Galleggiante V, Serino G, Massaro M, Santino A.

Curr Pharm Des. 2017;23(16):2289-2298. doi: 10.2174/1381612823666170215143541. Review.

PMID:
28215151
7.

Dendritic Cells Modulate Iron Homeostasis and Inflammatory Abilities Following Quercetin Exposure.

Galleggiante V, De Santis S, Cavalcanti E, Scarano A, De Benedictis M, Serino G, Caruso ML, Mastronardi M, Pinto A, Campiglia P, Kunde D, Santino A, Chieppa M.

Curr Pharm Des. 2017;23(14):2139-2146. doi: 10.2174/1381612823666170112125355.

PMID:
28079005
8.

The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma.

De Palma G, Sallustio F, Curci C, Galleggiante V, Rutigliano M, Serino G, Ditonno P, Battaglia M, Schena FP.

J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016.

9.

Secretory leukoprotease inhibitor is required for efficient quercetin-mediated suppression of TNFα secretion.

De Santis S, Kunde D, Serino G, Galleggiante V, Caruso ML, Mastronardi M, Cavalcanti E, Ranson N, Pinto A, Campiglia P, Santino A, Eri R, Chieppa M.

Oncotarget. 2016 Nov 15;7(46):75800-75809. doi: 10.18632/oncotarget.12415.

10.

Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics.

Ragone R, Sallustio F, Piccinonna S, Rutigliano M, Vanessa G, Palazzo S, Lucarelli G, Ditonno P, Battaglia M, Fanizzi FP, Schena FP.

Diseases. 2016 Jan 22;4(1). pii: E7. doi: 10.3390/diseases4010007.

11.

Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma.

Lucarelli G, Rutigliano M, Sanguedolce F, Galleggiante V, Giglio A, Cagiano S, Bufo P, Maiorano E, Ribatti D, Ranieri E, Gigante M, Gesualdo L, Ferro M, de Cobelli O, Buonerba C, Di Lorenzo G, De Placido S, Palazzo S, Bettocchi C, Ditonno P, Battaglia M.

Medicine (Baltimore). 2015 Nov;94(46):e2117. doi: 10.1097/MD.0000000000002117.

12.

Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38.

Grossi V, Lucarelli G, Forte G, Peserico A, Matrone A, Germani A, Rutigliano M, Stella A, Bagnulo R, Loconte D, Galleggiante V, Sanguedolce F, Cagiano S, Bufo P, Trabucco S, Maiorano E, Ditonno P, Battaglia M, Resta N, Simone C.

Autophagy. 2015 Nov 2;11(11):2102-2113. doi: 10.1080/15548627.2015.1091910.

13.

Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.

Lucarelli G, Rutigliano M, Galleggiante V, Giglio A, Palazzo S, Ferro M, Simone C, Bettocchi C, Battaglia M, Ditonno P.

Expert Rev Mol Diagn. 2015;15(9):1211-24. doi: 10.1586/14737159.2015.1069711. Epub 2015 Jul 15. Review.

PMID:
26174441
14.

Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.

Lucarelli G, Galleggiante V, Rutigliano M, Sanguedolce F, Cagiano S, Bufo P, Lastilla G, Maiorano E, Ribatti D, Giglio A, Serino G, Vavallo A, Bettocchi C, Selvaggi FP, Battaglia M, Ditonno P.

Oncotarget. 2015 May 30;6(15):13371-86.

15.

Pre-existing type 2 diabetes mellitus is an independent risk factor for mortality and progression in patients with renal cell carcinoma.

Vavallo A, Simone S, Lucarelli G, Rutigliano M, Galleggiante V, Grandaliano G, Gesualdo L, Campagna M, Cariello M, Ranieri E, Pertosa G, Lastilla G, Selvaggi FP, Ditonno P, Battaglia M.

Medicine (Baltimore). 2014 Dec;93(27):e183. doi: 10.1097/MD.0000000000000183.

16.

Isolation and characterization of cancer stem cells in renal cell carcinoma.

Lucarelli G, Galleggiante V, Rutigliano M, Vavallo A, Ditonno P, Battaglia M.

Urologia. 2015 Jan-Mar;82(1):46-53. doi: 10.5301/uro.5000099. Epub 2014 Nov 25. Review.

PMID:
25451878
17.

Emerging urinary markers of renal injury in obstructive nephropathy.

Lucarelli G, Mancini V, Galleggiante V, Rutigliano M, Vavallo A, Battaglia M, Ditonno P.

Biomed Res Int. 2014;2014:303298. doi: 10.1155/2014/303298. Epub 2014 Jul 2. Review.

18.

CTR2 identifies a population of cancer cells with stem cell-like features in patients with clear cell renal cell carcinoma.

Galleggiante V, Rutigliano M, Sallustio F, Ribatti D, Ditonno P, Bettocchi C, Selvaggi FP, Lucarelli G, Battaglia M.

J Urol. 2014 Dec;192(6):1831-41. doi: 10.1016/j.juro.2014.06.070. Epub 2014 Jun 24.

PMID:
24972308
19.

Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma.

Lucarelli G, Ditonno P, Bettocchi C, Vavallo A, Rutigliano M, Galleggiante V, Larocca AM, Castellano G, Gesualdo L, Grandaliano G, Selvaggi FP, Battaglia M.

Dis Markers. 2014;2014:689795. doi: 10.1155/2014/689795. Epub 2014 Feb 17.

20.

Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer.

Lucarelli G, Ditonno P, Bettocchi C, Spilotros M, Rutigliano M, Vavallo A, Galleggiante V, Fanelli M, Larocca AM, Germinario CA, Maiorano E, Selvaggi FP, Battaglia M.

Future Oncol. 2013 Jun;9(6):899-907. doi: 10.2217/fon.13.50.

PMID:
23718310

Supplemental Content

Loading ...
Support Center